A phase II, randomized, study of weekly APG101+ reirradiation versus reirradiation in progressive glioblastoma

W Wick, H Fricke, K Junge, G Kobyakov, T Martens… - Clinical Cancer …, 2014 - AACR
Harald Fricke; Harald Fricke … Kunz and Harald Fricke are employees of Apogenix. No
potential conflicts of interest were disclosed by the other authors. …

APG350 induces superior clustering of TRAIL receptors and shows therapeutic antitumor efficacy independent of cross-linking via Fcγ receptors

…, BA Abhari, P Hohenberger, S Fulda, H Fricke… - Molecular cancer …, 2013 - AACR
Cancer cells can be specifically driven into apoptosis by activating Death-receptor-4 (DR4;
TRAIL-R1) and/or Death-receptor-5 (DR5; TRAIL-R2). Albeit showing promising preclinical …

[1-11C] Acetate as a quantitative perfusion tracer in myocardial PET

…, W Burchert, AR Börner, H Fricke… - Journal of Nuclear …, 2001 - Soc Nuclear Med
Our objective was to investigate the properties of [1- 11 C]acetate as a quantitative perfusion
tracer for myocardial PET studies. Methods: We determined the flow dependence of the …

Efficacy and safety of autologous dendritic cell–based immunotherapy, docetaxel, and prednisone vs placebo in patients with metastatic castration-resistant prostate …

…, N Sousa, A Bahl, S Hussain, H Fricke… - JAMA …, 2022 - jamanetwork.com
Importance DCVAC/PCa is an active cellular immunotherapy designed to initiate an immune
response against prostate cancer. Objective To evaluate the efficacy and safety of DCVAC/…

Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG‐PET

…, H Kolbe, J van den Hoff, H Fricke… - … : official journal of the …, 2001 - Wiley Online Library
Studies of resting regional cerebral glucose consumption (rCMRGlc) in nondemented patients
with Parkinson's disease (PD) have produced conflicting results, reporting both reduced …

Correlates of local cerebral blood flow (CBF) in normal pressure hydrocephalus patients before and after shunting—A retrospective analysis of [15O] H2O PET-CBF …

…, A Samii, E Weckesser, J van den Hoff, H Fricke… - Clinical neurology and …, 2008 - Elsevier
OBJECTIVES: Findings in local cerebral blood flow (rCBF) in Normal pressure hydrocephalus
(NPH) have always been challenged by the variable and inconsistent relation to clinical …

Biocompatible membranes preserve residual renal function in patients undergoing regular hemodialysis

J Hartmann, H Fricke, H Schiffl - American journal of kidney diseases, 1997 - Elsevier
Initiation of hemodialysis causes a further decrease of residual renal function (RRF). To assess
the impact of the biocompatibility of the dialysis membrane, we performed a prospective …

High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis

C Küchle, H Fricke, E Held, H Schiffl - American journal of nephrology, 1996 - karger.com
Amyloidosis due to the retention of β 2 -microgιobulin (β 2 -MG) is a frequent complication of
hemodialysis (HD). Significant amounts of β 2 -MG can be removed from the body by highly …

Attenuation correction of myocardial SPECT perfusion images with low-dose CT: evaluation of the method by comparison with perfusion PET

E Fricke, H Fricke, R Weise, A Kammeier… - Journal of nuclear …, 2005 - Soc Nuclear Med
In cardiac SPECT, specificity is significantly affected by artifacts due to photon absorption.
As the success of attenuation correction depends mainly on high-quality attenuation maps, …

[HTML][HTML] Proteinase 3 gene polymorphisms and Wegener's granulomatosis

M Gencik, S Meller, S Borgmann, H Fricke - Kidney international, 2000 - Elsevier
Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Background Wegener's
granulomatosis (WG) is a rare systemic autoimmune disease characterized by small-vessel …